FDA Registration

FDA 510(k) Submission & QSR 820 / QMSR Compliance Readiness

Providing FDA 510(k) premarket notification drafting, Substantial Equivalence (SE) analysis, FDA response support, and readiness review aligned with QSR 820 / QMSR.

Substantial Equivalence & FDA 510(k) Compilation

Most moderate-risk (Class II) devices require a 510(k) submission before U.S. market entry. We help you identify a suitable predicate device, conduct strict equivalence comparisons, organize validation data (biocompatibility, performance, software), and draft high-quality dossiers.

  • Predicate device search and comparison analysis
  • Complete dossier compilation and eCopy submission format packaging
  • FDA deficiency letter (Additional Information request) response support
  • FDA establishment registration and product listing support

Navigating FDA QSR 820 & QMSR Transition

The U.S. FDA has finalized its Quality System Regulation (QMSR), incorporating ISO 13485 into 21 CFR Part 820. We offer professional gap analysis and QMS transition services, along with mock FDA inspections based on QSIT methodology to prevent FDA 483s.

  • QMSR new regulation and ISO 13485 gap assessment
  • Full-process mock FDA inspections and QSIT response training
  • FDA 483 and Warning Letter response (CAPA evidence closure)